Classification of normogonadotropic infertility: Polycystic ovaries diagnosed by ultrasound versus endocrine characteristics of polycystic ovary syndrome

Fertility and Sterility

Volumn 67, Issue 3, 1997, Pages 452-458

  Van Santbrink, Evert J P ^a,b   Hop, Wim C ^a,c   Fauser, Bart C J M ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Department of Obstetrics and Gynaecology   (Netherlands)

^c Department of Epidemiology and Biostatistics ^*

Author keywords

androstenedione; anovulation; infertility; LH; PCOS; Polycystic ovaries; testosterone; transvaginal sonography

Indexed keywords

ANDROSTENEDIONE; FOLLITROPIN; LUTEINIZING HORMONE; TESTOSTERONE;

ACCURACY; ADULT; AMENORRHEA; ANOVULATION; ARTICLE; CONTROLLED STUDY; FEMALE; FEMALE INFERTILITY; HUMAN; HYPERANDROGENISM; MAJOR CLINICAL STUDY; OLIGOMENORRHEA; OVARY FOLLICLE; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PRIORITY JOURNAL; TRANSVAGINAL ECHOGRAPHY;

EID: 0031026729     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(97)80068-4     Document Type: Article

References (26)

1. Stein IF, Leventhal ML. Amenorrhea associated with bilateral polycystic ovaries. Am J Ob Gyn 1935;29:181-91.
2. Scheele F, Hompes PGA, van der Meer M, Schoute E, Schoemaker J. The effects of a gonadotrophin-releasing hormone agonist on treatment with low-dose follicle-stimulating hormone in polycystic ovary syndrome. Hum Reprod 1993;5:699-704.
3. Lobo R. Disturbances of androgen secretion and metabolism in polycystic ovary syndrome. Clin Obstet Gynaecol 1985;12:605-20.
4. Ardaens Y, Robert Y, Lemaitre L, Fossati P, Dewailly D. Polycystic ovary disease: contribution of vaginal endosonography and reassessment of ultrasonic diagnosis. Fertil Steril 1991;55:1062-8.
5. Adams J, Poison DW, Abdulwahid N, Morris DV, Franks S, Mason HD, et al. Multifollicular ovaries: clinical and endocrine features and response to pulsatile GnRH. Lancet 1985;2:1375-8.
6. Balen AH, Conway GS, Kaltsas G, Techatraisak K, Manning PJ, West C, et al. Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod 1995;8:2107-11.
7. Fox R, Corrigan E, Thomas PA, Hull MGR. The diagnosis of polycystic ovaries in women with oligo-amenorroea: predictive power of endocrine tests. Clin Endocrinol (Oxf) 1991;34:127-31.
8. Takahashi K, Eda Y, Okada S, Abu-Musa A, Yoshino K, Kitao M. Morphological assessment of polycystic ovaries using transvaginal ultrasound. Hum Reprod 1993;6:844-9.
9. Puzigaca Z, Prelevic GM, Stretenovic Z, Balint-Peric L. Ovarian enlargement as a possible marker of androgen activity in polycystic ovary syndrome. Gynecol Endocrinol 1991;5:167-74.
10. Pache TD, de Jong FH, Hop WC, Fauser BCJM. Association between ovarian changes assessed by transvaginal sonography and clinical and endocrine signs of the polycystic ovary syndrome. Fertil Steril 1993;59:544-9.
11. Obhrai M, Lynch S, Holder G, Jackson R, Tang L, Butt WR. Hormonal studies on women with polycystic ovaries diagnosed by ultrasound. Clin Endocrinol (Oxf) 1990;32:467-74.
12. Dewailly D, Robert Y, Helin I, Ardaens Y, Thomas-Desrousseaux P, Lemaitre L, et al. Ovarian stromal hypertrophy in hyperandrogenic women. Clin Endocrinol (Oxf) 1994;41:557-62.
13. Robinson S, Rodin DA, Deacon A, Wheeler MJ, Clayton RN. Which hormone tests for the diagnosis of polycystic ovary disease? Br J Obstet Gynaecol 1992;99:232-8.
14. Pache TD, Hop WC, Wladimiroff JW, Schipper J, Fauser BCJM. Transvaginal sonography and abnormal ovarian appearance in menstrual cycle disturbances. Ultrasound Med Biol 1991;17:589-93.
15. Sample WF, Lippe BM, Gyepes MT. Grayscale ultrasonography of the normal female pelvis. Radiology 1977;125:477-83.
16. van Santbrink EJP, Hop WC, van Dessel TJHM, de Jong FH, Fauser BCJM. Decremental follicle-stimulating hormone and dominant follicle development during the normal menstrual cycle. Fertil Steril 1995;64:37-43.
17. Fauser BCJM, Pache TD, Lamberts S, de Jong FH, Hop WC, Dahl KD. Serum immunoreactive and bioactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities with and without polycystic ovary disease. J Clin Endocrinol Metab 1991;73:811-7.
18. Dunaif A, Givens JR, Haseltine F, Merriam GR, editors. The polycystic ovary syndrome. Cambridge: Blackwell Scientific, 1992.
19. Poison DW, Wadsworth J, Adams J, Franks S. Polycystic ovaries - a common finding in normal women. Lancet 1988;1:870-2.
20. Farquhar CM, Birdsall M, Manning P, Mitchell JM, France JT. The prevalence of polycystic ovaries on ultrasound scanning in a population of randomly selected women. Aust NZ J Obstet Gynaecol 1994;34:67-72.
21. el Tabbakh GH, Lotfy I, Azab I, Rahman HA, Southren AL, Aleem FA. Correlation of the ultrasonic appearance of the ovaries in PCOD and the clinical, hormonal and laparoscopic findings. Am J Obstet Gynecol 1986;154:892-5.
22. World Health Organization. WHO manual for the standardized investigation and diagnosis of the infertile couple. Cambridge: Cambridge University Press, 1993.
23. Abdel Gadir A, Khatim MS, Mowafi RS, Alnaser HMI, Muharib NS, Shaw RW. Implications of ultrasonically diagnosed polycystic ovaries. I. Correlations with basal hormonal profiles. Hum Reprod 1992;4:453-7.
24. Lobo RA, Kletzky OA, Campeau JD, diZerega GS. Elevated bioactive luteinizing hormone in women with the polycystic ovary syndrome. Fertil Steril 1983;39:674-8.
25. Fauser BCJM, Pache TD, Hop WC, de Jong FH, Dahl KD. The significance of a single serum luteinizing hormone measurement in women with cycle disturbances: discrepancies between immunoreactive and bioactive hormone estimates. Clin Endocrinol (Oxf) 1992;37:445-52.
26. Rittmaster RS. Androgen conjugates as a measure of hyperandrogenism. Semin Reprod Endocrinol 1994;12:45-50.